Packages cover the most common needs of our clients, but we customize these packages according to your needs.
DILIsym Services, Inc. utilizes the DILIsym® software to evaluate the Drug Induced Liver Injury (DILI) and hepatotoxic risk for compounds throughout the clinical development pipeline.
